Jump to content

MET amplication news


Recommended Posts

I just learned from my Oncologist that they (her and a consulting Onc who has recently published a paper on MET Amplification) have determined that Crizotnib is more likely to be effective if the mutation has ten or more copies. Also, the side effects that Crizotnib has are usually less troublesome if it is used before immunotherapy rather than after it. This is what my understanding is anyway after hearing it third person.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.